3-deoxyglucose has been researched along with lysine in 4 studies
Studies (3-deoxyglucose) | Trials (3-deoxyglucose) | Recent Studies (post-2010) (3-deoxyglucose) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
---|---|---|---|---|---|
19 | 1 | 2 | 37,449 | 622 | 11,213 |
Protein | Taxonomy | 3-deoxyglucose (IC50) | lysine (IC50) |
---|---|---|---|
Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyama, I; Katsuzaki, T; Miyazaki, T; Niwa, T; Shimokata, K; Takayama, F; Tsukushi, S | 1 |
Bretzel, RG; Brownlee, M; Hammes, HP; Lin, J; Schleicher, E | 1 |
Arbeiter, K; Bonzel, KE; Fischbach, M; Misselwitz, J; Pieper, AK; Rieger, S; Schaefer, F; Schmitt, CP; von Heyl, D | 1 |
Nakaya, I; Nakayama, K; Nakayama, M; Soma, J; Tezuka, Y; Yahata, M | 1 |
1 trial(s) available for 3-deoxyglucose and lysine
Article | Year |
---|---|
Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content.
Topics: Adolescent; Child; Child, Preschool; Cross-Over Studies; Deoxyglucose; Dialysis Solutions; Glycation End Products, Advanced; Humans; Infant; Lysine; Molecular Weight; Osmolar Concentration; Peritoneal Cavity; Peritoneal Dialysis; Time Factors | 2007 |
3 other study(ies) available for 3-deoxyglucose and lysine
Article | Year |
---|---|
Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
Topics: Adult; Aged; Aldehyde Reductase; Arginine; Creatinine; Deoxyglucose; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Glycation End Products, Advanced; Hemoglobins; Humans; Imidazoles; In Vitro Techniques; Lysine; Male; Middle Aged; Polymers; Renal Dialysis; Sorbitol; Uremia | 1999 |
Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Leukocyte Common Antigens; Lysine; Male; Middle Aged; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyruvaldehyde; Risk Factors; T-Lymphocytes | 1999 |
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease Progression; Female; Humans; Japan; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyruvaldehyde; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Up-Regulation | 2019 |